Literature DB >> 24972737

Religiously affiliated intensive care unit patients receive more aggressive end-of-life care.

Myrick C Shinall1, Jesse M Ehrenfeld2, Oscar D Guillamondegui3.   

Abstract

BACKGROUND: Previous studies among cancer patients have demonstrated that religious patients receive more aggressive end-of-life (EOL) care. We sought to examine the effect of religious affiliation on EOL care in the intensive care unit (ICU) setting.
MATERIALS AND METHODS: We conducted a retrospective review of all patients admitted to any adult ICU at a tertiary academic center in 2010 requiring at least 2 d of mechanical ventilation. EOL patients were those who died within 30 d of admission. Hospital charges, ventilator days, hospital days, and days until death were used as proxies for intensity of care among the EOL patients. Multivariate analysis using multiple linear regression, zero-truncated negative binomial regression, and Cox proportional hazard model were used.
RESULTS: A total of 2013 patients met inclusion criteria; of which, 1355 (67%) affirmed a religious affiliation. The EOL group had 334 patients, with 235 (70%) affirming a religious affiliation. The affiliated and nonaffiliated patients had similar levels of acuity. Controlling for demographic and medical confounders, religiously affiliated patients in the EOL group incurred 23% (P = 0.030) more hospital charges, 25% (P = 0.035) more ventilator days, 23% (P = 0.045) more hospital days, and 30% (P = 0.036) longer time until death than their nonaffiliated counterparts. Among all included patients, survival did not differ significantly among affiliated and nonaffiliated patients (log-rank test P = 0.317), neither was religious affiliation associated with a difference in survival on multivariate analysis (hazard ratio of death for religious versus nonreligious patients 0.95, P = 0.542).
CONCLUSIONS: Compared with nonaffiliated patients, religiously affiliated patients receive more aggressive EOL care in the ICU. However, this high-intensity care does not translate into any significant difference in survival.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Futility; Religion; Spirituality; Terminal care

Mesh:

Year:  2014        PMID: 24972737     DOI: 10.1016/j.jss.2014.05.074

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  When Religion and Medicine Clash: Non-beneficial Treatments and Hope for a Miracle.

Authors:  Philip M Rosoff
Journal:  HEC Forum       Date:  2019-06

2.  Spiritual Health and Outcomes in Muslim ICU Patients: A Nationwide Cross-Sectional Study.

Authors:  Farshid R Bashar; Amir Vahedian-Azimi; Mahmood Salesi; Mohammadreza Hajiesmaeili; Seyedpouzhia Shojaei; Behrooz Farzanegan; Reza Goharani; Seyed J Madani; Kivan G Moghaddam; Sevak Hatamian; Hosseinali J Moghaddam; Abilio Arrascaeta-Llanes; Andrew C Miller
Journal:  J Relig Health       Date:  2018-12

3.  Islamic perspectives on clinical intervention near the end-of-life: We can but must we?

Authors:  Aasim I Padela; Omar Qureshi
Journal:  Med Health Care Philos       Date:  2017-12

Review 4.  Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review.

Authors:  Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton
Journal:  J Pain Symptom Manage       Date:  2019-10-19       Impact factor: 3.612

5.  Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States.

Authors:  Alessandra Ferrario; Xin Xu; Fang Zhang; Dennis Ross-Degnan; J Frank Wharam; Anita K Wagner
Journal:  JCO Oncol Pract       Date:  2020-11-10

6.  Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life.

Authors:  Katrina Spilsbury; Lorna Rosenwax
Journal:  BMC Palliat Care       Date:  2017-12-08       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.